Regulatory PathRegulatory requirements compared

Active substance

Dermatophagoides farinae

Open in the medicines table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
ALLERGENIC EXTRACT - STANDARDIZED MITE DERMATOPHAGOIDES FARINAE0223132110000 UNIT / MLLIQUID · INTRACUTANEOUS; SUBCUTANEOUSGREER LABORATORIES INC
ALLERGENIC EXTRACT STANDARDIZED MITE DF (10,000 AU/ML)0222395310000 UNIT / MLSOLUTION · SUBCUTANEOUS; PERCUTANEOUSJUBILANT HOLLISTERSTIER LLC
ALLERGENIC EXTRACT STANDARDIZED MITE DF (30,000 AU/ML)0222396130000 UNIT / MLSOLUTION · SUBCUTANEOUS; PERCUTANEOUSJUBILANT HOLLISTERSTIER LLC
ALLERGENIC EXTRACT, STANDARDARDIZED MITE, D. FARINAE0221708210000 UNIT / MLLIQUID · PERCUTANEOUS; INTRADERMAL; SUBCUTANEOUSALK-ABELLO INC

UK MHRA United Kingdom — marketing authorisations

ProductAuthorisationHolderLegal status
D. FARINAE 10,000 DU/ML ODCPL 17087/0017ALLERGY THERAPEUTICS (UK) LIMITEDPOM
SOLUPRICK SQ DERMATOPHAGOIDES FARINAE 10 HEPPL 10085/0046ALK ABELLO A-SPOM

Combinations containing Dermatophagoides farinae

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.